Covalon Technologies Ltd. - Asset Resilience Ratio

Latest as of December 2015: 6.33%

Covalon Technologies Ltd. (COV) has an Asset Resilience Ratio of 6.33% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Covalon Technologies Ltd. (COV) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CA$548.06K
≈ $396.46K USD Cash + Short-term Investments

Total Assets

CA$8.66 Million
≈ $6.26 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2007–2016)

This chart shows how Covalon Technologies Ltd.'s Asset Resilience Ratio has changed over time. See COV net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Covalon Technologies Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Covalon Technologies Ltd..

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CA$0.00 0%
Short-term Investments CA$548.06K 6.33%
Total Liquid Assets CA$548.06K 6.33%

Asset Resilience Insights

  • Limited Liquidity: Covalon Technologies Ltd. maintains only 6.33% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Covalon Technologies Ltd. Industry Peers by Asset Resilience Ratio

Compare Covalon Technologies Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Alcon AG
SW:ALC
Medical Instruments & Supplies 0.26%
iRay Technology Co Ltd
SHG:688301
Medical Instruments & Supplies 0.68%
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Medical Instruments & Supplies 29.19%
Jiangsu Nanfang Medical
SHG:603880
Medical Instruments & Supplies 2.27%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
I.Ceram SA
PA:ALICR
Medical Instruments & Supplies -1.61%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%

Annual Asset Resilience Ratio for Covalon Technologies Ltd. (2007–2016)

The table below shows the annual Asset Resilience Ratio data for Covalon Technologies Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2016-09-30 0.00% CA$0.00
≈ $0.00
CA$6.49 Million
≈ $4.69 Million
--
2015-09-30 7.17% CA$547.04K
≈ $395.72K
CA$7.63 Million
≈ $5.52 Million
+0.37pp
2014-09-30 6.80% CA$541.00K
≈ $391.35K
CA$7.96 Million
≈ $5.76 Million
-2.02pp
2013-09-30 8.82% CA$500.00K
≈ $361.69K
CA$5.67 Million
≈ $4.10 Million
+0.43pp
2012-09-30 8.38% CA$500.00K
≈ $361.69K
CA$5.96 Million
≈ $4.31 Million
+3.02pp
2011-09-30 5.36% CA$500.00K
≈ $361.69K
CA$9.32 Million
≈ $6.74 Million
+0.52pp
2010-09-30 4.85% CA$500.00K
≈ $361.69K
CA$10.32 Million
≈ $7.47 Million
+0.96pp
2009-09-30 3.89% CA$500.00K
≈ $361.69K
CA$12.87 Million
≈ $9.31 Million
-48.64pp
2008-09-30 52.52% CA$9.08 Million
≈ $6.57 Million
CA$17.29 Million
≈ $12.51 Million
+6.82pp
2007-09-30 45.70% CA$9.25 Million
≈ $6.69 Million
CA$20.24 Million
≈ $14.64 Million
--
pp = percentage points

About Covalon Technologies Ltd.

V:COV Canada Medical Instruments & Supplies
Market Cap
$38.48 Million
CA$53.19 Million CAD
Market Cap Rank
#22821 Global
#832 in Canada
Share Price
CA$1.94
Change (1 day)
+2.65%
52-Week Range
CA$1.56 - CA$2.88
All Time High
CA$9.18
About

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more